India already has talent, digital infrastructure, entrepreneurial energy, clinical expertise, and policy momentum. The next phase demands coordinated execution and building institutions that can hold the ecosystem together over time
A one-shot gene-editing cholesterol therapy could soon be a reality
The company is expected to conduct further studies to confirm the long-term efficacy and safety of Vijoice in both adult and paediatric patients
The company said the breadth of its showcase reflects “progress from its differentiated oncology pipeline in solid tumors and hematologic malignancies,”
This collaboration across the NIPER network- Raebareli, Hajipur, Ahmedabad and Hyderabad is strengthening translational research and opnMe access
NGI will deliver full end-to-end workflows using both EpiFinder cNUC and EpiFinder GenomePro
The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego
Funding to support clinical development, gene therapy pipeline expansion and GMP manufacturing capabilities
The Union Minister reviewed DST-supported SATHI-BHU facility
India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
